Factors that affect the size of platelet aggregates in epinephrine-induced activation: A study using the particle counting method based upon light scattering

Thrombosis Research

Volumn 81, Issue 5, 1996, Pages 515-523

  Satoh, Kaneo ^a   Ozaki, Yukio ^a   Qi, Ruomei ^a   Yang, Libo ^a   Asazuma, Naoki ^a   Yatomi, Yutaka ^a   Kume, Shoji ^a  

^a UNIVERSITY OF YAMANASHI   (Japan)

Author keywords

aggregate size; cytochalasin B; epinephrine; glycoprotein IIb IIIa; Na+ H+ exchanger; platelet aggregation; thromboxane A2

Indexed keywords

15 CYCLOPENTYL 14 OXO 13 AZA 16,17,18,19,20 PENTANORPINANE THROMBOXANE A2; 5 (N ETHYL N ISOPROPYL)AMILORIDE; 7 (3 BENZENESULFONAMIDOBICYCLO[2.2.1]HEPT 2 YL) 5 HEPTENOIC ACID; ACETYLSALICYLIC ACID; ADRENALIN; FIBRINOGEN RECEPTOR; KETANSERIN; NITROPRUSSIDE SODIUM; PROSTAGLANDIN SYNTHASE INHIBITOR; THROMBOXANE A2 RECEPTOR BLOCKING AGENT;

ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; THROMBOCYTE AGGREGATION;

EID: 0029925163     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/0049-3848(96)00026-6     Document Type: Article

References (29)

1. ROWSELL HC, HEGARDT B, DOWNIE HG, MUSTARD JF and MURPHY EA. Adrenaline and experimental thrombosis. Br. J. Haematol. 12, 66-73, 1966.
2. MILLS DCB, and ROBERTS GCK. Effects of adrenaline on human blood platelets.. J. Physiol. 193, 443-453, 1967
3. FOUQUE F and VARGAFTIG BB. Potentiation and inhibition by clonidine of PAF-acether induced human platelet activation. Eur. J. Pharmacol. 135, 211-218, 1987.
4. THOMAS DP. The role of platelet catecholamines in the aggregation of platelets by collagen and thrombin. Exp. Biol. Med. 3, 129-134, 1968.
5. DE CHAFFOY DE COURCELLES D, ROEVENS P, VAN BELLE H and DE CLERCK F. The synergistic effect of serotonin and epinephrine on the human platelet at the level of signal transduction. FEBS Lett. 219, 283-288, 1987.
6. + exchange regulates receptor-mediated phospholipase A2 activation in human platelets. J. Biol. Chem. 261, 8667-8673, 1986.
7. SHATTIL SJ, BUDZYNSKI A, and SCRUTTON MC. Epinephrine induces platelet fibrinogen receptor expression, fibrinogen binding, and aggregation in whole blood in the absence of other excitatory agonists. Blood 73, 150-158, 1989
8. BORN GVR. Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature 194, 927-929, 1962
9. OZAKI Y, SATOH K, YATOMI Y, YAMAMOTO T, SHIRASAWA Y, and KUME S. Detection of platelet aggregates with a particle counting method using light scattering. Anal. Biochem. 218, 284-294, 1994
10. KITEK A, and BREDDIN K. Optical density variations and microscopic observations in the evaluation of platelet shape change and microaggregate formation. Thromb. Haemost. 44, 154-158, 1980
11. + exchanger in human platelets by 1,2-dioctanoylglycerol, a protein kinase C activator. Thromb. Haemost. 64, 165-171, 1990
12. ZAVOICO GB, CRAGOE EJ Jr, and FEINSTEIN MB. Regulation of intracellular pH in human platelets. J. Biol. Chem. 261, 13160-13167, 1986
13. RAO AK, and KOWALSKA M. : ADP-induced platelet shape change and mobilization of cytoplasmic ionized calcium are mediated by distinct binding sites on platelets. Blood 70, 751-756, 1987
14. 3H]ketanserin. Eur. J. Pharmacol. 88, 125-130, 1983
15. KINGLOUGH-RATHBONE RL, PACKHAM MA, and MUSTARD JF. in "Methods in Hematology: Measurements of Platelet Function" (L.A. Harker and T.S. Zimmerman, eds.), p.64. Chrchill-Livingstone, Edinburgh, Scotland, 1983
16. LANZA F, BERETZ A, STIERLE A, HANAU D, KUBINA M, and CAZENAVE J-P. Epinephrine potentiates human platelet activation but is not an aggregating agent. Am. J. Physiol. 255, HI276-1288, 1988
17. NISHIZUKA Y. The role of protein kinase C in cell surface signal transduction and tumour promotion. Nature 308, 693-695, 1984
18. GOLDEN A, BRUGGE JS, and SHATTIL SJ. Role of platelet membrane glycoprotein IIb-IIIa in agonist-induced tyrosine phosphorylation of platelet proteins. J. Cell Biol. 111, 3117-3127, 1990
19. 2+ entry in human platelets. FEBS Lett. 315, 242-246, 1993
20. JUNG CY, and RAMPAL AL. Cytochalasin B binding sites and glucose transport carrier in human erythrocyte ghosts. J. Biol. Chem. 252, 5456-5463, 1977
21. SCHIFF PB, and HORWITZ SB. Taxol stabilizes microtubules in mouse fibroblast cells. Proc. Natl. Acad. Sci. USA 77, 1561-1565, 1980
22. SEAMON KB, and DALY JW. Forskolin, cyclic AMP and cellular physiology. Trends Pharmacol. Sci. 4, 120-132, 1983
23. RADOSKI MW, PALMER RMJ, and MONCADA S. The antiaggregating properties of vascular endothelium: interaction between prostacyclin and nitric oxide. Br. J. Pharmcol. 92, 639-646, 1987
24. SCHULTZ KD, SCHULTZ K, and SCHULTZ G. Sodium nitroprusside and other smooth muscle-relaxants increase cyclic GMP levels in rat ductus deferens. Nature 265, 750-751, 1977
25. ANDRIEUX A, HURDRY-CLERGEON G, RYCKEWAERT JJ, CHAPEL A, GINSBERG MH, LOW EF, AND MARGUERIE G. Amino acid sequences in fibrinogen mediating its interaction with its platelet receptor, GPIIb/IIIa. J. Biol. Chem. 264, 9258-9265, 1989
26. IKEDA Y, HANDA M, KAWANO K, KAMATA T, MURATA M, ARAKI Y, ANBO H, KAWAI Y, WATANABE K, ITAGAKI I, SAKAI K, and RUGGERI ZM. The role of von Willebrand factor and fibrinogen in platelet aggregation under varying shear stress. J. Clin. Invest. 87, 1234-1240, 1991
27. TUSZYNSKI GP, ROTHMAN V, MURPHY A, SIEGLER K, SMITH L, SMITH S, KARCZEWSKI J, and KNUDSEN KA. Thrombospondin promotes cell-substratum adhesion. Science 236, 1570-1573, 1987
28. LAWRENCE MB, and SPRINGER TA. Leukocytes roll on a selectin at physiologic flow rates: distinction from and prerequisite for adhesion through integrins. Cell 65, 859-863, 1991
29. METZELAAR MJ, KORTEWEG J, SIXMA JJ, and NIEUWENHUIS HK. Biochemical characterization of PECAM-1 (CD41 antigen) on human platelets. Thromb. Haemost. 66, 700-707, 1991